Paper19789364
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.
Hoque MO and 21 others. Cancer Epidemiol Biomarkers Prev, 2009. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Papers, record 19789364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19789364
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma, Ductal, Breast | Major topic |
| CpG Islands | Major topic |
| DNA Methylation | Major topic |
| Adult | |
| Disease Progression | |
| Female | |
| Humans | |
| Middle Aged | |
| Polymerase Chain Reaction | |
| Promoter Regions, Genetic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA006973 | NCI NIH HHS | United States | P30CA006973 | PubMed | NIH RePORTER |
| P50 CA098252 | NCI NIH HHS | United States | P50CA098252 | PubMed and NIH | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12800196 | Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. | Int J Cancer | 2003 | https://conductscience.org/library/papers/12800196 | PubMed |
| 2 | 2567800 | In-situ breast cancer: the EORTC consensus meeting. | Lancet | 1989 | https://conductscience.org/library/papers/2567800 | PubMed |
| 3 | 14580249 | The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. | Breast Cancer Res | 2003 | https://conductscience.org/library/papers/14580249 | PubMed |
| 4 | 7585573 | E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. | Cancer Res | 1995 | https://conductscience.org/library/papers/7585573 | PubMed |
| 5 | 8638126 | Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. | Science | 1996 | https://conductscience.org/library/papers/8638126 | PubMed |
| 6 | 3742467 | Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies. | Cancer | 1986 | https://conductscience.org/library/papers/3742467 | PubMed |
| 7 | 9496256 | Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. | J Pathol | 1997 | https://conductscience.org/library/papers/9496256 | PubMed |
| 8 | 8256859 | Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8256859 | PubMed |
| 9 | 11717336 | Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. | J Natl Cancer Inst | 2001 | https://conductscience.org/library/papers/11717336 | PubMed |
| 10 | 14614048 | Methylation profiling of benign and malignant breast lesions and its application to cytopathology. | Mod Pathol | 2003 | https://conductscience.org/library/papers/14614048 | PubMed |
| 11 | 12960130 | Detection of gene promoter hypermethylation in fine needle washings from breast lesions. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12960130 | PubMed |
| 12 | 7781895 | Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. | Dev Biol | 1995 | https://conductscience.org/library/papers/7781895 | PubMed |
| 13 | 11309270 | A gene hypermethylation profile of human cancer. | Cancer Res | 2001 | https://conductscience.org/library/papers/11309270 | PubMed |
| 14 | 11602373 | Cancer burden in the year 2000. The global picture. | Eur J Cancer | 2001 | https://conductscience.org/library/papers/11602373 | PubMed |
| 15 | 16007089 | Distinct epigenetic changes in the stromal cells of breast cancers. | Nat Genet | 2005 | https://conductscience.org/library/papers/16007089 | PubMed |
| 16 | 10397238 | Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. | Cancer Res | 1999 | https://conductscience.org/library/papers/10397238 | PubMed |
| 17 | 10655057 | Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Nat Genet | 2000 | https://conductscience.org/library/papers/10655057 | PubMed |
| 18 | 10667580 | Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. | Cancer Res | 2000 | https://conductscience.org/library/papers/10667580 | PubMed |
| 19 | 3677009 | Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. | Cancer | 1987 | https://conductscience.org/library/papers/3677009 | PubMed |
| 20 | 9365159 | E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9365159 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751248 | The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751248 | PubMed |
| 40809180 | Ketone body, as an emerging modulator of metabolic reprogramming and epigenetics in breast cancer. | Iran J Basic Med Sci | 2025 | https://conductscience.org/library/papers/40809180 | PubMed |
| 39261937 | Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/39261937 | PubMed |
| 39138705 | E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes. | Histopathology | 2025 | https://conductscience.org/library/papers/39138705 | PubMed |
| 37881785 | Methylation of ESR1 promoter induced by SNAI2-DNMT3B complex promotes epithelial-mesenchymal transition and correlates with poor prognosis in ERα-positive breast cancers. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37881785 | PubMed |
| 30416383 | Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation. | Int J Biol Sci | 2018 | https://conductscience.org/library/papers/30416383 | PubMed |
| 30306389 | Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer. | J Mammary Gland Biol Neoplasia | 2018 | https://conductscience.org/library/papers/30306389 | PubMed |
| 29682089 | Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer. | Clin Epigenetics | 2018 | https://conductscience.org/library/papers/29682089 | PubMed |
| 28979331 | Study of the Role of siRNA Mediated Promoter Methylation in DNMT3B Knockdown and Alteration of Promoter Methylation of CDH1, GSTP1 Genes in MDA-MB -453 Cell Line. | Iran J Pharm Res | 2017 | https://conductscience.org/library/papers/28979331 | PubMed |
| 28403857 | Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28403857 | PubMed |
| 28186977 | Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation. | Oncotarget | 2017 | https://conductscience.org/library/papers/28186977 | PubMed |
| 27478702 | Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies. | PeerJ | 2016 | https://conductscience.org/library/papers/27478702 | PubMed |
| 27308263 | Quantitation of CDH1 promoter methylation in formalin-fixed paraffin-embedded tissues of breast cancer patients using differential high resolution melting analysis. | Adv Biomed Res | 2016 | https://conductscience.org/library/papers/27308263 | PubMed |
| 27191268 | Quantitative assessment of the association between APC promoter methylation and breast cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27191268 | PubMed |
| 27065772 | DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification. | EXCLI J | 2016 | https://conductscience.org/library/papers/27065772 | PubMed |
| 26987530 | Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/26987530 | PubMed |
| 26585467 | Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26585467 | PubMed |
| 26510686 | Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26510686 | PubMed |
| 26425077 | Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26425077 | PubMed |
| 25155055 | BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer. | Cancer Sci | 2014 | https://conductscience.org/library/papers/25155055 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19789364
GET https://conductscience.org/api/papers/v1/19789364/authors?page=2